Women's Hormones 101
CPD
7 Points
Videos
9
Duration
7 Hours
Build practical foundations in the hormone health of women
Women’s Hormones 101 provides a clear clinical foundation in hormone signalling and the roles of estradiol, progesterone and testosterone across the reproductive lifespan. It moves beyond “stages” to help you recognise hormone-related presentations as multi-system patterns, and apply more confident decision-making around assessment and treatment – including HRT.
You’ll learn how to assess presentations more confidently, choose appropriate investigations, and make clearer decisions around hormone treatment options, monitoring and follow-up – expanding your practice, supporting safer care and better patient outcomes.
You’ll learn how to assess presentations more confidently, choose appropriate investigations, and make clearer decisions around hormone treatment options, monitoring and follow-up – expanding your practice, supporting safer care and better patient outcomes.
Key outcomes from Women's Hormones 101
How this module improves your clinical practice
Hormone-related presentations often show up as broad, non-specific symptom clusters – mood and sleep disruption, cognitive changes, palpitations, joint pain, fatigue, weight change and menstrual changes – making them easy to misattribute without a clear physiological framework.
Women’s Hormones 101 strengthens day-to-day clinical practice by providing the foundations to recognise hormone-related patterns earlier, use investigations more appropriately and make safer decisions around hormone treatment, monitoring and follow-up. By integrating this understanding of hormone health into your consultations, you can enhance patient assessment, support more realistic treatment planning, strengthen clinical decision-making and improve risk awareness with appropriate signposting.
Women’s Hormones 101 strengthens day-to-day clinical practice by providing the foundations to recognise hormone-related patterns earlier, use investigations more appropriately and make safer decisions around hormone treatment, monitoring and follow-up. By integrating this understanding of hormone health into your consultations, you can enhance patient assessment, support more realistic treatment planning, strengthen clinical decision-making and improve risk awareness with appropriate signposting.
Who this module is good for
Course Content
Inclusive Language Statement
Throughout, our courses we refer to perimenopause, menopause and other hormone-related conditions (for example premenstrual syndrome and premenstrual dysphoric disorder) that commonly affect women. In this context, the terms “women”, “woman” and “female” are used inclusively to describe anyone who experiences these hormonal changes, including people who may identify as transgender, gender-fluid, agender or non-binary. We also refer to andropause and other hormone-related conditions that commonly affect men, the terms “men”, “man” and “male” are used inclusively to describe anyone who experiences these hormonal changes, including people who may identify as transgender, gender-fluid, agender or non-binary.

